Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6

Kim,Min  Hee; Ahn,Hee  Kyung; Lee,Eun‑Ji; Kim,Su‑Jeong; Kim,Ye‑Ryung; Park,Joo‑Won; Park,Woo‑Jae

doi:10.3892/ijmm.2016.2835

Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6

Authors:
- Min Hee Kim
- Hee Kyung Ahn
- Eun‑Ji Lee
- Su‑Jeong Kim
- Ye‑Ryung Kim
- Joo‑Won Park
- Woo‑Jae Park
View Affiliations

Affiliations: Department of Biochemistry, School of Medicine, Gachon University, Incheon 406‑799, Republic of Korea, Division of Haematology and Oncology, Department of Internal Medicine, Gachon University Gil Medical Centre, Incheon 405‑760, Republic of Korea, Department of Biochemistry, School of Medicine, Ewha Womans University, Seoul 158‑710, Republic of Korea
Published online on: December 22, 2016 https://doi.org/10.3892/ijmm.2016.2835
Pages: 453-462

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chronic inflammation is associated with the pathogenesis of type 2 diabetes and diabetic complications, and palmitate has been nominated as a candidate for the molecular link between these disorders. Recently, a crucial role of ceramide in inflammation and metabolic diseases has been reported. Therefore, in this study, we investigated whether ceramide formation is involved in palmitate‑induced hepatic inflammation in vitro and in vivo. Ceramide can be generated either by the de novo pathway or by sphingomyelin degradation, and six different ceramide synthases (CerS) determine the specific acyl chain length of ceramide in mammals. We examined the roles of CerS and sphingomyelinases (SMases) in the secretion of inflammatory cytokines, such as tumour necrosis factor (TNF)‑α, interleukin (IL)‑1β, and IL‑6 in Hep3B cells. Among the six CerS, CerS6 overexpression uniquely elevated TNF‑α secretion via p38 mitogen‑activated protein kinase (MAPK) activation. In addition, the treatment of CerS6 overexpressing cells with palmitate synergistically increased cytokine secretion. However, neither palmitate treatment nor CerS6 overexpression altered lipopolysaccharide (LPS)-induced cytokine secretion. Instead, the activation of acidic (A)‑SMase was involved in LPS‑induced cytokine secretion via the MAPK/NF‑κB pathway. Finally, the suppression of ceramide generation via A‑SMase inhibition or de novo ceramide synthesis decreased high‑fat diet‑induced hepatic cytokine production in vivo. On the whole, our results revealed that CerS6 played a role in TNF‑α secretion, and palmitate augmented inflammatory responses in pathophysiological conditions in which CerS6 is overexpressed. In addition, A‑SMase activation was shown to be involved in LPS‑induced inflammatory processes, suggesting that the modulation of CerS6 and A‑SMase may be a therapeutic target for controlling hepatic inflammation.

View Figures

View References

1	Esser N, Legrand-Poels S, Piette J, Scheen AJ and Paquot N: Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 105:141–150. 2014. View Article : Google Scholar : PubMed/NCBI
2	Monteiro R and Azevedo I: Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010:2896452010. View Article : Google Scholar : PubMed/NCBI
3	Boden G: Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 18:139–143. 2011. View Article : Google Scholar : PubMed/NCBI
4	Ståhlman M, Pham HT, Adiels M, Mitchell TW, Blanksby SJ, Fagerberg B, Ekroos K and Borén J: Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes. Diabetologia. 55:1156–1166. 2012. View Article : Google Scholar : PubMed/NCBI
5	Pillon NJ, Azizi PM, Li YE, Liu J, Wang C, Chan KL, Hopperton KE, Bazinet RP, Heit B, Bilan PJ, et al: Palmitate-induced inflammatory pathways in human adipose microvascular endothelial cells promote monocyte adhesion and impair insulin transcytosis. Am J Physiol Endocrinol Metab. 309:E35–E44. 2015. View Article : Google Scholar : PubMed/NCBI
6	Haus JM, Kashyap SR, Kasumov T, Zhang R, Kelly KR, Defronzo RA and Kirwan JP: Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes. 58:337–343. 2009. View Article : Google Scholar :
7	Brozinick JT, Hawkins E, Hoang Bui H, Kuo MS, Tan B, Kievit P and Grove K: Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet. Int J Obes. 37:1064–1070. 2013. View Article : Google Scholar
8	Park WJ and Park JW: The effect of altered sphingolipid acyl chain length on various disease models. Biol Chem. 396:693–705. 2015. View Article : Google Scholar : PubMed/NCBI
9	Park JW, Park WJ and Futerman AH: Ceramide synthases as potential targets for therapeutic intervention in human diseases. Biochim Biophys Acta. 1841:671–681. 2014. View Article : Google Scholar
10	Venkataraman K, Riebeling C, Bodennec J, Riezman H, Allegood JC, Sullards MC, Merrill AH Jr and Futerman AH: Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro) ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J Biol Chem. 277:35642–35649. 2002. View Article : Google Scholar : PubMed/NCBI
11	Lahiri S and Futerman AH: LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor. J Biol Chem. 280:33735–33738. 2005. View Article : Google Scholar : PubMed/NCBI
12	Mizutani Y, Kihara A and Igarashi Y: Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem J. 390:263–271. 2005. View Article : Google Scholar : PubMed/NCBI
13	Riebeling C, Allegood JC, Wang E, Merrill AH Jr and Futerman AH: Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem. 278:43452–43459. 2003. View Article : Google Scholar : PubMed/NCBI
14	Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill AH Jr and Futerman AH: Characterization of ceramide synthase 2: Tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem. 283:5677–5684. 2008. View Article : Google Scholar : PubMed/NCBI
15	Mizutani Y, Kihara A and Igarashi Y: LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro) ceramide synthase with relatively broad substrate specificity. Biochem J. 398:531–538. 2006. View Article : Google Scholar : PubMed/NCBI
16	Mesicek J, Lee H, Feldman T, Jiang X, Skobeleva A, Berdyshev EV, Haimovitz-Friedman A, Fuks Z and Kolesnick R: Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal. 22:1300–1307. 2010. View Article : Google Scholar : PubMed/NCBI
17	Goñi FM and Alonso A: Sphingomyelinases: Enzymology and membrane activity. FEBS Lett. 531:38–46. 2002. View Article : Google Scholar : PubMed/NCBI
18	Tolman KG, Fonseca V, Dalpiaz A and Tan MH: Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 30:734–743. 2007. View Article : Google Scholar : PubMed/NCBI
19	Roux JC, Dura E, Moncla A, Mancini J and Villard L: Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur J Neurosci. 25:1915–1922. 2007. View Article : Google Scholar : PubMed/NCBI
20	Glaros EN, Kim WS, Wu BJ, Suarna C, Quinn CM, Rye KA, Stocker R, Jessup W and Garner B: Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration. Biochem Pharmacol. 73:1340–1346. 2007. View Article : Google Scholar : PubMed/NCBI
21	Ali M, Fritsch J, Zigdon H, Pewzner-Jung Y, Schütze S and Futerman AH: Altering the sphingolipid acyl chain composition prevents LPS-GLN-mediated hepatic failure in mice by disrupting TNFR1 internalization. Cell Death Dis. 4:e9292013. View Article : Google Scholar
22	Halasiddappa LM, Koefeler H, Futerman AH and Hermetter A: Oxidized phospholipids induce ceramide accumulation in RAW 264.7 macrophages: Role of ceramide synthases. PLoS One. 8:e700022013. View Article : Google Scholar : PubMed/NCBI
23	Jeong YM, Park WJ, Kim MK, Baek KJ, Kwon NS, Yun HY and Kim DS: Leucine-rich glioma inactivated 3 promotes HaCaT keratinocyte migration. Wound Repair Regen. 21:634–640. 2013. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
25	Choi S, Kim JA, Kim TH, Li HY, Shin KO, Lee YM, Oh S, Pewzner-Jung Y, Futerman AH and Suh SH: Altering sphingolipid composition with aging induces contractile dysfunction of gastric smooth muscle via K(Ca) 1.1 upregulation. Aging Cell. 14:982–994. 2015. View Article : Google Scholar : PubMed/NCBI
26	Shaner RL, Allegood JC, Park H, Wang E, Kelly S, Haynes CA, Sullards MC and Merrill AH Jr: Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J Lipid Res. 50:1692–1707. 2009. View Article : Google Scholar :
27	Campbell J, Ciesielski CJ, Hunt AE, Horwood NJ, Beech JT, Hayes LA, Denys A, Feldmann M, Brennan FM and Foxwell BM: A novel mechanism for TNF-alpha regulation by p38 MAPK: Involvement of NF-kappa B with implications for therapy in rheumatoid arthritis. J Immunol. 173:6928–6937. 2004. View Article : Google Scholar : PubMed/NCBI
28	Józefowski S, Czerkies M, Łukasik A, Bielawska A, Bielawski J, Kwiatkowska K and Sobota A: Ceramide and ceramide 1-phosphate are negative regulators of TNF-α production induced by lipopolysaccharide. J Immunol. 185:6960–6973. 2010. View Article : Google Scholar
29	El Alwani M, Wu BX, Obeid LM and Hannun YA: Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol Ther. 112:171–183. 2006. View Article : Google Scholar : PubMed/NCBI
30	Soriano JM, González L and Catalá AI: Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1. Prog Lipid Res. 44:345–356. 2005. View Article : Google Scholar : PubMed/NCBI
31	Dandona P, Aljada A and Bandyopadhyay A: Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol. 25:4–7. 2004. View Article : Google Scholar
32	Bikman BT and Summers SA: Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest. 121:4222–4230. 2011. View Article : Google Scholar : PubMed/NCBI
33	Holland WL, Brozinick JT, Wang L-P, Hawkins ED, Sargent KM, Liu Y, Narra K, Hoehn KL, Knotts TA, Siesky A, et al: Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5:167–179. 2007. View Article : Google Scholar : PubMed/NCBI
34	Blais DR, Vascotto SG, Griffith M and Altosaar I: LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Invest Ophthalmol Vis Sci. 46:4235–4244. 2005. View Article : Google Scholar : PubMed/NCBI
35	Chen CL, Lin CF, Chang WT, Huang WC, Teng CF and Lin YS: Ceramide induces p38 MAPK and JNK activation through a mechanism involving a thioredoxin-interacting protein-mediated pathway. Blood. 111:4365–4374. 2008. View Article : Google Scholar : PubMed/NCBI
36	Park WJ, Park JW, Merrill AH Jr, Storch J, Pewzner-Jung Y and Futerman AH: Hepatic fatty acid uptake is regulated by the sphingolipid acyl chain length. Biochim Biophys Acta. 1841:1754–1766. 2014. View Article : Google Scholar : PubMed/NCBI
37	Russo SB, Baicu CF, Van Laer A, Geng T, Kasiganesan H, Zile MR and Cowart LA: Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes. J Clin Invest. 122:3919–3930. 2012. View Article : Google Scholar : PubMed/NCBI
38	Schiffmann S, Ferreirós N, Birod K, Eberle M, Schreiber Y, Pfeilschifter W, Ziemann U, Pierre S, Scholich K, Grösch S and Geisslinger G: Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis. J Immunol. 188:5723–5733. 2012. View Article : Google Scholar : PubMed/NCBI
39	Jin J, Zhang X, Lu Z, Perry DM, Li Y, Russo SB, Cowart LA, Hannun YA and Huang Y: Acid sphingomyelinase plays a key role in palmitic acid-amplified inflammatory signaling triggered by lipopolysaccharide at low concentrations in macrophages. Am J Physiol Endocrinol Metab. 305:E853–E867. 2013. View Article : Google Scholar : PubMed/NCBI
40	Schilling JD, Machkovech HM, He L, Sidhu R, Fujiwara H, Weber K, Ory DS and Schaffer JE: Palmitate and lipopolysaccharide trigger synergistic ceramide production in primary macrophages. J Biol Chem. 288:2923–2932. 2013. View Article : Google Scholar :
41	Cuschieri J, Bulger E, Billgrin J, Garcia I and Maier RV: Acid sphingomyelinase is required for lipid Raft TLR4 complex formation. Surg Infect (Larchmt). 8:91–106. 2007. View Article : Google Scholar
42	Liu G, Friggeri A, Yang Y, Park YJ, Tsuruta Y and Abraham E: miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci USA. 106:15819–15824. 2009. View Article : Google Scholar : PubMed/NCBI
43	Kawane K, Tanaka H, Kitahara Y, Shimaoka S and Nagata S: Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation. Proc Natl Acad Sci USA. 107:19432–19437. 2010. View Article : Google Scholar : PubMed/NCBI